Previous studies have demonstrated that KPNA2 is a potential biomarker in multiple forms of cancer, including breast cancer, lung cancer, gastric cancer, colon cancer, prostate cancer and upper tract urothelial carcinoma [15–18]. Here, KPNA2 is linked to colonic neoplasm.